Process View
The directed orientation of lymphocyte signaling molecules and associated membrane rafts towards a chemokine gradient or a contact point with an appropriate activating cell.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "establishment of lymphocyte polarity"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
CCL4 | chemokine (C-C motif) ligand 4 | 0.995 | Human | |
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.984 | ||
CCL5 | chemokine (C-C motif) ligand 5 | 0.981 | Human | |
IL8 | interleukin 8 | 0.961 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.958 | Human | |
CCL2 | chemokine (C-C motif) ligand 2 | 0.935 | Human | |
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.909 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.899 | Human | |
CCR5 | chemokine (C-C motif) receptor 5 | 0.882 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.854 | ||
IDE | insulin-degrading enzyme | 0.754 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.685 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.651 | Human | |
CCL19 | chemokine (C-C motif) ligand 19 | 0.609 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.539 | Human | |
CCR7 | chemokine (C-C motif) receptor 7 | 0.520 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.464 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.406 | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.392 | ||
TNF | tumor necrosis factor | 0.352 | ||
CCL7 | chemokine (C-C motif) ligand 7 | 0.321 | Human | |
IL1B | interleukin 1, beta | 0.281 | ||
CCL3 | chemokine (C-C motif) ligand 3 | 0.272 | Human | |
DARC | Duffy blood group, chemokine receptor | 0.271 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.249 | ||
MYL9 | myosin, light chain 9, regulatory | 0.205 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.195 | ||
SELE | selectin E | 0.180 | ||
CD83 | CD83 molecule | 0.176 | ||
TPM4 | tropomyosin 4 | 0.168 | ||
ZYX | zyxin | 0.164 | ||
UBD | ubiquitin D | 0.154 | ||
IFNG | interferon, gamma | 0.152 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.130 | ||
FPR3 | formyl peptide receptor 3 | 0.121 | ||
IL7R | interleukin 7 receptor | 0.119 | ||
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.110 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.108 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.108 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.106 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.105 | ||
RGS1 | regulator of G-protein signaling 1 | 0.100 | ||
FLNA | filamin A, alpha | 0.084 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.081 | ||
IL2RG | interleukin 2 receptor, gamma | 0.078 | ||
LAMP3 | lysosomal-associated membrane protein 3 | 0.078 | ||
SLAMF8 | SLAM family member 8 | 0.077 | ||
CCL11 | chemokine (C-C motif) ligand 11 | 0.073 | Human | |
ARRB1 | arrestin, beta 1 | 0.071 | ||
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.067 | ||
CH25H | cholesterol 25-hydroxylase | 0.062 | ||
IL1RN | interleukin 1 receptor antagonist | 0.062 | ||
CLEC10A | C-type lectin domain family 10, member A | 0.060 | ||
IDO1 | indoleamine 2,3-dioxygenase 1 | 0.059 | ||
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.054 | ||
C1QA | complement component 1, q subcomponent, A chain | 0.053 | ||
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.052 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.051 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.046 | ||
C1QB | complement component 1, q subcomponent, B chain | 0.043 | ||
APOC1 | apolipoprotein C-I | 0.043 | ||
XCL2 | chemokine (C motif) ligand 2 | 0.042 | Human | |
CCL20 | chemokine (C-C motif) ligand 20 | 0.040 | Human | |
IL32 | interleukin 32 | 0.039 | ||
TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.037 | ||
KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.037 | ||
MSC | musculin | 0.037 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.036 | ||
CCL21 | chemokine (C-C motif) ligand 21 | 0.035 | ||
CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.035 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.032 | ||
CD80 | CD80 molecule | 0.031 | ||
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.031 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.030 | ||
CCL17 | chemokine (C-C motif) ligand 17 | 0.029 | Human | |
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.029 | ||
SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.029 | ||
XCL1 | chemokine (C motif) ligand 1 | 0.029 | Human | |
CCR3 | chemokine (C-C motif) receptor 3 | 0.028 | ||
GNLY | granulysin | 0.028 | ||
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.027 | ||
CCL23 | chemokine (C-C motif) ligand 23 | 0.026 | Human | |
CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.026 | ||
IL21R | interleukin 21 receptor | 0.025 | ||
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.024 | ||
SLAMF7 | SLAM family member 7 | 0.024 | ||
CD69 | CD69 molecule | 0.024 | ||
IL18RAP | interleukin 18 receptor accessory protein | 0.024 | ||
IL2RB | interleukin 2 receptor, beta | 0.023 | ||
CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.023 | ||
INHBA | inhibin, beta A | 0.023 | ||
STAT4 | signal transducer and activator of transcription 4 | 0.022 | ||
NKG7 | natural killer cell group 7 sequence | 0.022 | ||
OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.022 | ||
NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.021 | ||
RGS16 | regulator of G-protein signaling 16 | 0.021 | ||
IL10 | interleukin 10 | 0.020 | ||
C2 | complement component 2 | 0.020 | ||
DPT | dermatopontin | 0.020 | ||
PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.020 | ||
C1QC | complement component 1, q subcomponent, C chain | 0.020 | ||
IL2RA | interleukin 2 receptor, alpha | 0.020 | ||
CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.019 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.019 | ||
WDR1 | WD repeat domain 1 | 0.019 | ||
SRGN | serglycin | 0.019 | ||
BATF | basic leucine zipper transcription factor, ATF-like | 0.019 | ||
TM7SF4 | transmembrane 7 superfamily member 4 | 0.018 | ||
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.018 | ||
CD163 | CD163 molecule | 0.018 | ||
CD1B | CD1b molecule | 0.018 | ||
TPSB2 | tryptase beta 2 (gene/pseudogene) | 0.018 | ||
DNASE1L3 | deoxyribonuclease I-like 3 | 0.017 | ||
CAP1 | CAP, adenylate cyclase-associated protein 1 (yeast) | 0.016 | ||
CCL1 | chemokine (C-C motif) ligand 1 | 0.015 | Human | |
ARHGAP15 | Rho GTPase activating protein 15 | 0.015 | ||
IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.015 | ||
KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.015 | ||
ACP5 | acid phosphatase 5, tartrate resistant | 0.015 | ||
MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.014 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.014 | ||
OASL | 2'-5'-oligoadenylate synthetase-like | 0.014 | ||
IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.014 | ||
CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.014 | ||
CHIT1 | chitinase 1 (chitotriosidase) | 0.014 | ||
NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.014 | ||
MARCO | macrophage receptor with collagenous structure | 0.013 | ||
CMKLR1 | chemokine-like receptor 1 | 0.013 | ||
MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.013 | ||
RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.013 | ||
CST7 | cystatin F (leukocystatin) | 0.013 | ||
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | 0.013 | ||
IL18R1 | interleukin 18 receptor 1 | 0.013 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.013 | ||
IL4 | interleukin 4 | 0.013 | ||
HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.012 | ||
ACTN4 | actinin, alpha 4 | 0.012 | ||
EZR | ezrin | 0.012 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.012 | ||
TRAF1 | TNF receptor-associated factor 1 | 0.012 | ||
TNFRSF4 | tumor necrosis factor receptor superfamily, member 4 | 0.012 | ||
IGL@ | immunoglobulin lambda locus | 0.012 | ||
TPSAB1 | tryptase alpha/beta 1 | 0.012 | ||
FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | 0.012 | ||
RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.012 | ||
IRF4 | interferon regulatory factor 4 | 0.012 | ||
LAG3 | lymphocyte-activation gene 3 | 0.012 | ||
ASCC2 | activating signal cointegrator 1 complex subunit 2 | 0.012 | ||
CCBP2 | chemokine binding protein 2 | 0.012 | ||
SH3RF1 | SH3 domain containing ring finger 1 | 0.012 | ||
CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.012 | ||
IL1A | interleukin 1, alpha | 0.012 | ||
IL13 | interleukin 13 | 0.012 | ||
PLA2G2D | phospholipase A2, group IID | 0.011 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.011 | ||
CD40LG | CD40 ligand | 0.011 | ||
LGALS2 | lectin, galactoside-binding, soluble, 2 | 0.011 | ||
IL1R2 | interleukin 1 receptor, type II | 0.011 | ||
FLNB | filamin B, beta | 0.011 | ||
GAB2 | GRB2-associated binding protein 2 | 0.011 | ||
HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.011 | ||
MYL6 | myosin, light chain 6, alkali, smooth muscle and non-muscle | 0.011 | ||
ICOS | inducible T-cell co-stimulator | 0.011 | ||
TREM2 | triggering receptor expressed on myeloid cells 2 | 0.011 | ||
MMP19 | matrix metallopeptidase 19 | 0.011 | ||
IL4I1 | interleukin 4 induced 1 | 0.010 | ||
MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.010 | ||
C3AR1 | complement component 3a receptor 1 | 0.010 | ||
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.010 |